Capstone Investment Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $707K | Sell |
25,610
-16,463
| -39% | -$454K | ﹤0.01% | 466 |
|
|
2025
Q1 | $1.19M | Sell |
42,073
-9,074
| -18% | -$257K | ﹤0.01% | 321 |
|
|
2024
Q4 | $2.13M | Sell |
51,147
-47,062
| -48% | -$1.96M | 0.01% | 275 |
|
|
2024
Q3 | $6.56M | Buy |
98,209
+79,899
| +436% | +$5.34M | 0.02% | 106 |
|
|
2024
Q2 | $2.17M | Buy |
18,310
+7,370
| +67% | +$875K | 0.01% | 201 |
|
|
2024
Q1 | $1.17M | Buy |
10,940
+3,034
| +38% | +$323K | ﹤0.01% | 484 |
|
|
2023
Q4 | $786K | Sell |
7,906
-46,956
| -86% | -$4.67M | ﹤0.01% | 393 |
|
|
2023
Q3 | $5.67M | Buy |
54,862
+14,050
| +34% | +$1.45M | 0.03% | 159 |
|
|
2023
Q2 | $4.96M | Buy |
40,812
+20,978
| +106% | +$2.55M | 0.02% | 141 |
|
|
2023
Q1 | $3.05M | Sell |
19,834
-20,565
| -51% | -$3.16M | 0.02% | 181 |
|
|
2022
Q4 | $7.26M | Sell |
40,399
-5,199
| -11% | -$934K | 0.05% | 131 |
|
|
2022
Q3 | $5.39M | Buy |
45,598
+8,651
| +23% | +$1.02M | 0.03% | 187 |
|
|
2022
Q2 | $5.28M | Sell |
36,947
-21,294
| -37% | -$3.04M | 0.03% | 176 |
|
|
2022
Q1 | $10M | Buy |
58,241
+17,112
| +42% | +$2.95M | 0.03% | 128 |
|
|
2021
Q4 | $10.4M | Buy |
41,129
+33,658
| +451% | +$8.55M | 0.02% | 128 |
|
|
2021
Q3 | $2.88M | Buy |
+7,471
| New | +$2.88M | 0.01% | 276 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 851 |
|
|
2020
Q4 | – | Sell |
-12,840
| Closed | -$908K | – | 715 |
|
|
2020
Q3 | $908K | Buy |
+12,840
| New | +$908K | ﹤0.01% | 205 |
|